We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Avacta Group Plc | LSE:AVCT | London | Ordinary Share | GB00BYYW9G87 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 1.04% | 48.50 | 47.00 | 47.50 | 47.75 | 45.75 | 47.75 | 2,975,500 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 10.06M | -39.19M | -0.1382 | -3.42 | 134.01M |
Date | Subject | Author | Discuss |
---|---|---|---|
26/1/2020 17:50 | Stop lying pale face , grow up .. can we get this loon muted | gooner1886 | |
26/1/2020 17:04 | The oncology sector in January post JP Morgan are having IPO's coming back to the market, at valuations which makes Avacta ridiculous cheap and the majors are out shopping. Avacta has Korean and US partners / deals and those companies are linked up with other major names as showed on the map.Avacta is a name that will attract much interest in the sector. | nordic1958 | |
26/1/2020 12:35 | Thinking off dipping my toe in here next week. Do we know why IPO (IP Group) reduced to 15%, is that a concern? | teataster | |
26/1/2020 12:34 | 'Unicorn potential' i.e. $1bn+ Market Cap From current $50m is a 20 bagger minimum That should be obvious from a single potential $300m deal with LG Chem The only thing holding UK bios back has been Woodford situation causing extreme risk aversion and illiquidity aversion from UK Institutional Investors Might take a few sector deals (i.e. US companies coming over buying up some names at big premia or some UK companies listing on Nasdaq) to break the logjam but it will happen eventually | the stigologist | |
26/1/2020 11:57 | "Next week #AVCT will become my largest holding. Will share notes I’m completing, later next week. Neer seen such share price appreciation potential in a Co over a 2 year period. 2 successful Phase I trials, validating AVCT’s 2 tech platforms in humans, offers unicorn potential." | tromso1 | |
26/1/2020 08:00 | Dropped due to the need to raise more cash imo. None of the good news has produced deals with much cash up front, and won't do until it's proven in man. If all goes well they should never need another fund raise. | money multipier | |
26/1/2020 02:54 | Been researching this today well trying, why the price drop from over 40s to where it is today in past 12 months?Seen latest rns alot of room to growth with relatively small mcap and not too many shares in issueMassive buying this week and hardly any sells | gooner1886 | |
26/1/2020 01:19 | I would argue my good friendThis one has more announcements Korean money And us investingIt is a simple biotech 4 folder | nordic1958 | |
25/1/2020 20:25 | I'm tempted to make it an outsize position | the stigologist | |
25/1/2020 18:47 | I originally decided to invest only what I was willing to lose here, but I’ve gone beyond that now.. it’s just too exciting an opportunity! | mikro1 | |
24/1/2020 22:24 | Volume of 4.14 million today. That's 3.6% of the company traded. free stock charts from uk.advfn.com | someuwin | |
24/1/2020 17:36 | Overhangs often offer great profit-making opportunities. The selling temporarily depresses the price and lets you build a decent stake at a low level. When the overhang clears, price is free to move up again on any buying. And the move back up can sometimes be rapid as buyers start to realise there is nothing to hold the price back any more. | x54v | |
24/1/2020 17:24 | "Overhang"means that there is a known seller , ie. an institution which for whatever reason have been selling, however just watch shareholder register and you will find specialist Micro Cap Fund PremierMiton is holding a chunk. | nordic1958 | |
24/1/2020 17:09 | Bought a few at 18.75 Dbottom confirmed on eod close above 21.5, min tp approx 25.25 Potential turn showing 3/2/2020 | bamboo2 | |
24/1/2020 17:07 | Can anyone that knows more about these things explain this "overhang", in a little more detail? In relation to Avacta of course. | milkmonsta | |
24/1/2020 16:16 | Yes, the buying is relentless. If the same buying pressure continues when the overhang clears then the price should start moving higher very rapidly. | x54v | |
24/1/2020 16:04 | Buying pressure is growing here. | someuwin | |
24/1/2020 16:04 | These are LG Life science partners:Avacta up there and off course Astra Zeneca,as they are with ADC Therapeutics etc. PartnersAstraZenecaA | nordic1958 | |
24/1/2020 16:00 | PartnersAstraZenecaA | nordic1958 | |
24/1/2020 15:47 | "Up to 300k #AVCT shares added on the day. Taking a 3 year time horizon and believe this company has the potential to provide extraordinary returns over that period." | tromso1 | |
24/1/2020 15:19 | Heavy volume again. | x54v | |
24/1/2020 15:14 | Daewoong on there too. Were LG so impressed they introduced Avacta to Daewoong ? | the stigologist |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions